Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akima, S., Kent, A., Reynolds, G. J., Gallagher, M., and Falk, M. C., Indomethacin and renal impairment in neonates. Pediatr. Nephrol., 19, 490–493 (2004).
Amoozgar, H., Ghodstehrani, M., and Pishva, N., Oral ibuprofen and ductus arteriosus closure in full-term neonates: a prospective case-control study. Pediatr. Cardiol., 31, 40–43 (2010).
Aranda, J. V., Clyman, R. I., Van, O. B., Wozniak, P., Sosenko, I., Carlo, W. A., Ward, R. M., Shalwitz, R., Baggs, G., Seth, A., and Darko, L., A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am. J. Perinatol., 26, 235–245 (2009).
Bart, V. O., Koen, S., Dominiek, L., Hilde, V. D. B., Joost, W., Katya, D. G., and Jean-Paul, L., A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N. Engl. J. Med., 674–681 (2000).
Cherif, A., Khrouf, N., and Jabnoun, S., Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics, 122, e1256–e1261 (2008).
Chotigeat, U., Jirapapa, K., and Layangkool, T., A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J. Med. Assoc. Thai., 86, S563–S569 (2003).
Hermes-DeSantis, E. R. and Clyman, R. I., Patent ductus arteriosus: pathophysiology and management. J. Perinatol., 26Suppl 1, S14–S18 (2006).
Heyman, E., Morag, I., Batash, D., Keidar, R., Baram, S., and Berkovitch, M., Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics, 112, e354 (2003).
Katakam, L. I., Cotton, C. M., Goldberg, R. N., Dang, C. N., and Smith, P. B., Safety and effectiveness of indomethacin versus ibuprofen for treatment of patent ductus arteriosus. Am. J. Perinatol., 27, 425–429 (2010).
Moş, C., Patent ductus arteriosus. Med. Ultrason., 12, 153–156 (2010).
Neumann, R., Schulzke, S., and Buhrer, C., Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology, 102, 9–15 (2012).
Ohlssen, A., Walia, R., and Shah, S. S., Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst. Rev., 14, CD003481 (2010).
Rafat, M., Khalid, A., and Bosco, P., Role of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: systematic review and implications for clinical practice. Ann. Pediatr. Cardiol., 2, 120–126 (2009).
Ronal, L., Thomas, G. C., Parker, B. V. O., and Jacob, V. A., A meta-analysis of ibuprofen versus indometahcin for closure of patent ductus arteriosus. Eur. J. Pediatr., 164, 135–140 (2005).
SaBry, G. M. M. and Mohamed, S., Effect of oral ibuprofen on patent ductus arteriosus in premature newborns. J. Saudi Heart Assoc., 22, 7–12 (2010).
Sangtawesin, C., Sangtawesin, V., Lertsutthiwong, W., Kanjanapattanakul, W., Khorana, M., and Ayudhaya, J. K., Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants. J. Med. Assoc. Thai., 91Suppl 3, S28–S33 (2008).
Sekar, K. C. and Corff, K. E., Treatment of patent ductus arteriosus: indomethacin or ibuprofen? J. Perinatol., 28Suppl 1, S60–S62 (2008).
Shimada, S., Konoshi, M., Koyama, K., Nakamura, K., and Fujiwara, T., Closure of patent ductus arteriosus in preterm infants with mefenamic acid. Igaka No Ayumi., 130, 283–286 (1984)